<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01896349</url>
  </required_header>
  <id_info>
    <org_study_id>TIP-120288</org_study_id>
    <nct_id>NCT01896349</nct_id>
  </id_info>
  <brief_title>Interpersonal Psychotherapy for Treatment Resistant Depression</brief_title>
  <official_title>Efficacy of Interpersonal Psychotherapy in Treatment Resistant Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital de Clinicas de Porto Alegre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital de Clinicas de Porto Alegre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether combination of antidepressant drugs plus
      interpersonal psychotherapy is superior to antidepressant drugs alone in treatment resistant
      depression.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">November 2014</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hamilton Depression Scale (HAM-D) - continuous</measure>
    <time_frame>End point week 19 and Week 24</time_frame>
    <description>Score change on Hamilton depression scale from baseline to week 19 and to week 24</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Beck depression Inventory (BDI)</measure>
    <time_frame>End point week 19 and Week 24</time_frame>
    <description>Score change on Beck depression inventory from baseline to week 19 and to week 24</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Clinical Global Impression - Severity Scale (CGI-S) / dichotomous</measure>
    <time_frame>Endpoint (week-19) and week 24</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Whoqol brief - World Health Organization Quality of Life Instrument - Short version - Brazilian version</measure>
    <time_frame>Endpoint week 19 and week 24</time_frame>
    <description>Score change in Whoqol-breef from baseline to week 19 and week 24</description>
  </other_outcome>
  <other_outcome>
    <measure>Biological measures - BDFN, TBARS, TNF-alfa, IL-1, IL-6</measure>
    <time_frame>End point week 19 and Week 24</time_frame>
    <description>A blood sample will be collected at baseline, week 19 and week 24. Change in serum biomarkers will be evaluated - BDFN (Brain derived neurotrophic factor), TBARS (thiobarbituric acid reactive substance), TNF-alfa (tumor necrosis factor alfa), IL-1 (interleukin-1), IL-6 (interlekin-6) before and after treatment.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">74</enrollment>
  <condition>Treatment Resistant Depression</condition>
  <arm_group>
    <arm_group_label>IPT+antidepressant drugs</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Interpersonal Psychotherapy protocol (IPT) consist of 16 sessions of manualized interpersonal psychotherapy for depression. Patients are allowed to reschedule 3 sessions if they miss their appointments.
Antidepressant Drugs protocol consist of pharmacological management of depression, oriented by international guidelines, clinician´s free choice. Monotherapy or combinations are allowed. Antidepressant and drugs are: fluoxetine, sertraline, paroxetin, citalopram, escitalopram, fluvoxamine, venlafaxin, duloxetin, bupropion, lithium, risperidone, tranylcypromine, Imipramine, amitriptyline, clomipramine, nortriptyline, trazodone, mirtazapine, sulpiride.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Antidepressant Drugs</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Drugs protocol consist of pharmacological management of depression, oriented by international guidelines, clinician´s free choice.
Antidepressant Drugs protocol consist of pharmacological management of depression, oriented by international guidelines, clinician´s free choice. Monotherapy or combinations are allowed. Antidepressant and drugs are: fluoxetine, sertraline, paroxetine, citalopram, escitalopram, fluvoxamine, venlafaxine, duloxetine, bupropion, lithium, risperidone, tranylcypromine, Imipramine, amitriptyline, clomipramine, nortriptyline, trazodone, mirtazapine, sulpiride.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>IPT+ antidepressant drugs</intervention_name>
    <description>16 sessions of interpersonal psychotherapy plus antidepressant drugs.</description>
    <arm_group_label>IPT+antidepressant drugs</arm_group_label>
    <other_name>Interpersonal Psychotherapy</other_name>
    <other_name>Antidepressant drugs</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>fluoxetine</intervention_name>
    <description>Antidepressant drugs, clinician´s free choice oriented by guidelines. Monotherapy or combinations are allowed</description>
    <arm_group_label>IPT+antidepressant drugs</arm_group_label>
    <arm_group_label>Antidepressant Drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sertraline</intervention_name>
    <arm_group_label>IPT+antidepressant drugs</arm_group_label>
    <arm_group_label>Antidepressant Drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>paroxetine</intervention_name>
    <arm_group_label>IPT+antidepressant drugs</arm_group_label>
    <arm_group_label>Antidepressant Drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Citalopram</intervention_name>
    <arm_group_label>IPT+antidepressant drugs</arm_group_label>
    <arm_group_label>Antidepressant Drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>escitalopram</intervention_name>
    <arm_group_label>IPT+antidepressant drugs</arm_group_label>
    <arm_group_label>Antidepressant Drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>fluvoxamine</intervention_name>
    <arm_group_label>IPT+antidepressant drugs</arm_group_label>
    <arm_group_label>Antidepressant Drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Venlafaxine</intervention_name>
    <arm_group_label>IPT+antidepressant drugs</arm_group_label>
    <arm_group_label>Antidepressant Drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Duloxetine</intervention_name>
    <arm_group_label>IPT+antidepressant drugs</arm_group_label>
    <arm_group_label>Antidepressant Drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupropion</intervention_name>
    <arm_group_label>IPT+antidepressant drugs</arm_group_label>
    <arm_group_label>Antidepressant Drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lithium</intervention_name>
    <arm_group_label>IPT+antidepressant drugs</arm_group_label>
    <arm_group_label>Antidepressant Drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Risperidone</intervention_name>
    <arm_group_label>IPT+antidepressant drugs</arm_group_label>
    <arm_group_label>Antidepressant Drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tranylcypromine</intervention_name>
    <arm_group_label>IPT+antidepressant drugs</arm_group_label>
    <arm_group_label>Antidepressant Drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Imipramine</intervention_name>
    <arm_group_label>IPT+antidepressant drugs</arm_group_label>
    <arm_group_label>Antidepressant Drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>amitriptyline</intervention_name>
    <arm_group_label>IPT+antidepressant drugs</arm_group_label>
    <arm_group_label>Antidepressant Drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clomipramine</intervention_name>
    <arm_group_label>IPT+antidepressant drugs</arm_group_label>
    <arm_group_label>Antidepressant Drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>nortriptyline</intervention_name>
    <arm_group_label>IPT+antidepressant drugs</arm_group_label>
    <arm_group_label>Antidepressant Drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>trazodone</intervention_name>
    <arm_group_label>IPT+antidepressant drugs</arm_group_label>
    <arm_group_label>Antidepressant Drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mirtazapine</intervention_name>
    <arm_group_label>IPT+antidepressant drugs</arm_group_label>
    <arm_group_label>Antidepressant Drugs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sulpiride</intervention_name>
    <arm_group_label>IPT+antidepressant drugs</arm_group_label>
    <arm_group_label>Antidepressant Drugs</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary diagnose of unipolar treatment resistant depression

        Exclusion Criteria:

          -  Patients diagnose of: bipolar disorder, psychosis, high suicide risk, Intellectual
             disability, illicit drug dependence.

          -  Currently in or having received psychotherapy in the last 4 weeks
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marcelo PA Fleck, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Rio Grande do Sul / Hospital de Clínicas de Porto Alegre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Livia H Souza, MD</last_name>
    <phone>+55 51 98658701</phone>
    <email>liviahartmanndesouza@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marcelo PA Fleck, PhD</last_name>
    <phone>+55 51 33598294</phone>
    <email>mfleck.voy@terra.com.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Federal University of Rio Grande do Sul / Hospital de Clínicas de Porto Alegre (HCPA)</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <zip>90035-003</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lívia H Souza, MD</last_name>
      <phone>+55 5198658701</phone>
      <email>livia.hs@terra.com.br</email>
    </contact>
    <contact_backup>
      <last_name>Marcelo PA Fleck, MD, PhD</last_name>
      <phone>+55 51 33598294</phone>
      <email>mfleck.voy@terra.com.br</email>
    </contact_backup>
    <investigator>
      <last_name>Lívia H Souza, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marcelo PA Fleck, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marco Antonio K Caldieraro, MD, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lucas Spanemberg, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Edgar A Vares, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 1, 2013</study_first_submitted>
  <study_first_submitted_qc>July 10, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 11, 2013</study_first_posted>
  <last_update_submitted>July 10, 2013</last_update_submitted>
  <last_update_submitted_qc>July 10, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 11, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Psychotherapy, Treatment Resistant Depression, depression</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Treatment-Resistant</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antidepressive Agents</mesh_term>
    <mesh_term>Citalopram</mesh_term>
    <mesh_term>Bupropion</mesh_term>
    <mesh_term>Duloxetine Hydrochloride</mesh_term>
    <mesh_term>Sertraline</mesh_term>
    <mesh_term>Lithium Carbonate</mesh_term>
    <mesh_term>Fluoxetine</mesh_term>
    <mesh_term>Paroxetine</mesh_term>
    <mesh_term>Venlafaxine Hydrochloride</mesh_term>
    <mesh_term>Mirtazapine</mesh_term>
    <mesh_term>Amitriptyline</mesh_term>
    <mesh_term>Trazodone</mesh_term>
    <mesh_term>Nortriptyline</mesh_term>
    <mesh_term>Fluvoxamine</mesh_term>
    <mesh_term>Imipramine</mesh_term>
    <mesh_term>Clomipramine</mesh_term>
    <mesh_term>Tranylcypromine</mesh_term>
    <mesh_term>Sulpiride</mesh_term>
    <mesh_term>Risperidone</mesh_term>
    <mesh_term>Amitriptyline, perphenazine drug combination</mesh_term>
    <mesh_term>Dexetimide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

